Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection
ConditionB-cell Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJuventas Cell Therapy Ltd.
About this trial
This clinical trial adopts an observational research method to conduct annual follow-up and monitoring of patients receiving treatment with Inaticabtagene Autoleucel Injection after its commercialization, in order to evaluate the delayed adverse events of Inaticabtagene Autoleucel Injection.
Eligibility criteria
Qualifiers
Agree to sign an informed consent form for long-term follow-up studies.
Registered clinical trial patients with different indications for this product who have received at least one infusion of Inaticabtagene Autoleucel Injection in the past, as well as post market commercialized patients.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Inaticabtagene autoleucel Injection
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov